Stryker’s T2 ICF Nail System Offers Surgeons New Option for Patients Suffering from Serious Foot Conditions
Intramedullary Nailing System Provides Strong, Stable and Efficient Tool Designed to Promote Accurate Nail Insertion
Stryker’s Trauma & Extremities division today announced the launch of its T2® ICF Intramedullary nailing system, offering a solution for patients suffering from serious foot conditions such as Charcot foot—a condition associated with diabetes resulting in poor bone quality, possible nerve damage and potential foot ulcers.1
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005233/en/
Stryker’s new T2® ICF Intramedullary nailing system offers solution for patients suffering from serious foot conditions such as Charcot foot—a condition associated with diabetes. (Graphic: Business Wire)
The T2 ICF system is a stable product that provides a surgical option designed to prevent nail back out and promote fixation and accuracy. It is estimated that a leg is amputated every 30 seconds globally, and 85% of these amputations are the result of diabetic foot ulcers.2